Alphatec Holdings (ATEC) Cash from Investing Activities (2010 - 2026)

Alphatec Holdings (ATEC) reported Cash from Investing Activities of -$19.9 million for Q1 2026, down 71.32% on a YoY basis from -$69.4 million in Q1 2025, and down 26.43% sequentially from -$15.7 million in Q4 2025.

Alphatec Holdings (ATEC) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Alphatec Holdings (ATEC) has 17 years of Cash from Investing Activities data on file, last reported at -$19.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 71.32% year-over-year to -$19.9 million; the trailing twelve-month figure through Mar 2026 stood at -$61.7 million (up 13.27% YoY), and the FY2025 full-year result was -$53.4 million, up 42.65% from the prior year.
  • Cash from Investing Activities slipped to -$19.9 million in Q1 2026, from -$15.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$3.7 million in Q4 2024 to a low of -$75.6 million in Q2 2023.
  • A 5-year average of -$21.6 million and a median of -$15.7 million in 2025 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities tumbled 424.38% in 2023 and surged 86.72% in 2024, its largest moves.
  • Tracing ATEC's Cash from Investing Activities over 5 years: stood at -$14.8 million in 2022, then sank by 90.18% to -$28.2 million in 2023, then surged by 86.72% to -$3.7 million in 2024, then sank by 320.05% to -$15.7 million in 2025, then retreated by 26.43% to -$19.9 million in 2026.
  • Business Quant data shows ATEC's Cash from Investing Activities at -$19.9 million in Q1 2026, -$15.7 million in Q4 2025, and -$13.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 181.51 Bn 174.21 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.52 Bn 125.64 Bn 3.81 Bn -185.00 Mn
3 Medtronic 108.06 Bn 98.84 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 68.04 Bn 66.59 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn -92.80 Mn
6 GE HealthCare Technologies 28.45 Bn 26.17 Bn 1.98 Bn -2.50 Bn
7 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn -298.50 Mn
8 Smith & Nephew 26.88 Bn 26.30 Bn - -
9 Koninklijke Philips 25.42 Bn 22.29 Bn 2.07 Bn -475.32 Mn
10 Alphatec Holdings 1.35 Bn 1.21 Bn 136.48 Mn -19.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.89 Mn
Mar 31, 2026 -19.89 Mn
Dec 31, 2025 -15.74 Mn
Dec 31, 2025 -15.74 Mn
Sep 30, 2025 -13.89 Mn
Sep 30, 2025 -13.89 Mn
Jun 30, 2025 -12.17 Mn
Jun 30, 2025 -12.17 Mn
Mar 31, 2025 -11.61 Mn
Mar 31, 2025 -11.61 Mn
Dec 31, 2024 -3.75 Mn
Dec 31, 2024 -3.75 Mn
Sep 30, 2024 -19.88 Mn
Sep 30, 2024 -19.88 Mn
Jun 30, 2024 -35.89 Mn
Jun 30, 2024 -35.89 Mn
Mar 31, 2024 -33.62 Mn
Mar 31, 2024 -33.62 Mn
Dec 31, 2023 -28.21 Mn
Dec 31, 2023 -28.21 Mn